The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer☆
References (11)
- et al.
Ascorbic acid, cell proliferation and cancer
Lancet
(1972) The need for humanised science in evaluating medication
Lancet
(1972)- et al.
Urinary oxalate excretion and Vitamin-C supplements
Lancet
(1973) - et al.
Treatment of breast cancer
Lancet
(1972) - et al.
Seromucoid in the diagnosis of cancer
Scott. Med. J.
(1961)
There are more references available in the full text version of this article.
Cited by (254)
-
Vitamin C: From nutrition to oxygen sensing and epigenetics
2023, Redox Biology -
Cell signaling pathways based on vitamin C and their application in cancer therapy
2023, Biomedicine and Pharmacotherapy -
Interaction between bioactive carbonyl compounds and asparagine and impact on acrylamide
2023, Acrylamide in Food -
[<sup>18</sup>F]KS1, a novel ascorbate-based ligand images ROS in tumor models of rodents and nonhuman primates
2022, Biomedicine and Pharmacotherapy -
The potential role of vitamin C in empowering cancer immunotherapy
2022, Biomedicine and Pharmacotherapy
- ☆
-
Supported by a Research Grant from the Secretary of State for Scotland.
- a
-
Consultant Surgeon, Dunbartonshire Hospitals, and Fellow of the Institute of Orthomolecular Medicine. Address for reprints: Dr. Ewan Cameron FRCS, Vale of Leven District General Hospital, Alexandria, Dunbartonshire, G83 OUA (Scotland).
- b
-
Consultant Physician, Lanarkshire Hospitals.
Copyright © 1974 Published by Elsevier Ireland Ltd.